A classic case of ischemic central retinal vein occlusion with macular edema

Abstract

Central retinal vein occlusion (CRVO) is a significant cause of marked or total loss of vision in the middle-aged and elderly population. The patient was a 54-year-old man with a history of uncontrolled diabetes and was given seven intravitreal bevacizumab (Avastin) injections as treatment. The patient was advised to follow-up during the next 6 months, including gonioscopy and undilated examination of the iris to look for the iris/disc neovascularization. We presented a classic case of unilateral ischemic CRVO with macular edema, in whom diabetes is the leading risk factor. Close follow-up and diabetes control are advisable to prevent a similar scenario.

Keywords

• bevacizumab
• central retinal vein occlusion (crvo)
• diabetes
• fluorescein angiogram
• macular edema
• unilateral ischemic crvo